Funded Tech Companies
NGM Biopharmaceuticals
NGM Biopharmaceuticals, operating out of San Francisco, received equity investments from private investors, Topspin Partners and Tichenor Ventures.
Company Overview
Company Name
NGM Biopharmaceuticals
Company Status
Publicly-held
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
333 Oyster Point Blvd.
San Francisco, CA 94080
USA
San Francisco, CA 94080
USA
Phone
Website
Email Address
Company Background Information
Overview
NGM Biopharmaceuticals (Nasdaq: NGM) is a privately-held drug discovery company committed to the identification and development of transformational biologics for diabetes, obesity, muscle wasting and other cardiometabolic diseases.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
4/3/2019
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chairman
William Rieflin
Chief Executive Officer
David Woodhouse
Chief Medical Officer
Alex DePaoli
Chief Scientific Officer
Jin-Long Chen
Vice President
Wenyan Shen
VP - R & D
Hui Tian
Company Investors
- Topspin Partners
- Tichenor Ventures (McHenry Tichenor)
- The Column Group (David Goeddel)
- Rho Ventures (Mark Leschly)
- Prospect Venture Partners (David Schnell)
Browse more funded tech companies:
Share this article
About Our Venture Capital Database
Our data comes from VentureDeal.com, a market leader in private equity transaction data.
Additional Resources for Entrepreneurs